Response to Selective RET Inhibition With LOXO-292 in a Patient With RET Fusion-Positive Lung Cancer With Leptomeningeal Metastases. Academic Article uri icon

Overview

publication date

  • June 3, 2019

Identity

PubMed Central ID

  • PMC6724540

Scopus Document Identifier

  • 85077482329

Digital Object Identifier (DOI)

  • 10.1200/PO.19.00021

PubMed ID

  • 31485557

Additional Document Info

volume

  • 3